Sylvia E. Le Dévédec

2.8k total citations
70 papers, 1.9k citations indexed

About

Sylvia E. Le Dévédec is a scholar working on Molecular Biology, Cancer Research and Biomedical Engineering. According to data from OpenAlex, Sylvia E. Le Dévédec has authored 70 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 15 papers in Cancer Research and 15 papers in Biomedical Engineering. Recurrent topics in Sylvia E. Le Dévédec's work include Nanoplatforms for cancer theranostics (11 papers), Cancer, Hypoxia, and Metabolism (11 papers) and Cellular Mechanics and Interactions (9 papers). Sylvia E. Le Dévédec is often cited by papers focused on Nanoplatforms for cancer theranostics (11 papers), Cancer, Hypoxia, and Metabolism (11 papers) and Cellular Mechanics and Interactions (9 papers). Sylvia E. Le Dévédec collaborates with scholars based in Netherlands, United States and United Kingdom. Sylvia E. Le Dévédec's co-authors include Bob van de Water, Sylvestre Bonnet, Lucien N. Lameijer, Eytan Ruppin, Michael S. Meijer, Samantha L. Hopkins, Daniël Ernst, Sven H. C. Askes, Chantal Pont and Christian Frezza and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Angewandte Chemie International Edition.

In The Last Decade

Sylvia E. Le Dévédec

66 papers receiving 1.9k citations

Peers

Countries citing papers authored by Sylvia E. Le Dévédec

Since Specialization

Citations

This map shows the geographic impact of Sylvia E. Le Dévédec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvia E. Le Dévédec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvia E. Le Dévédec more than expected).

Fields of papers citing papers by Sylvia E. Le Dévédec

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvia E. Le Dévédec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvia E. Le Dévédec. The network helps show where Sylvia E. Le Dévédec may publish in the future.

Co-authorship network of co-authors of Sylvia E. Le Dévédec

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvia E. Le Dévédec. A scholar is included among the top collaborators of Sylvia E. Le Dévédec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvia E. Le Dévédec. Sylvia E. Le Dévédec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Single-cell Raman and mass spectrometry analysis to probe cellular heterogeneity in tamoxifen uptake and metabolism 2025 ·Analytical and Bioanalytical Chemistry ·(unknown), Yasmine Abouleila, Sylvia E. Le Dévédec, Thomas Hankemeier, Arno Germond, Ahmed Ali	0
2	Lipid dysregulation in triple negative breast cancer: Insights from mass spectrometry-based approaches 2025 ·Progress in Lipid Research ·(unknown), Ahmed Ali, (unknown), Sylvia E. Le Dévédec, Thomas Hankemeier	4
3	Spatio-temporal transcriptomic analysis reveals distinct nephrotoxicity, DNA damage, and regeneration response after cisplatin 2025 ·Cell Biology and Toxicology ·(unknown), Steven J. Kunnen, Panuwat Trairatphisan, Ciarán Fisher, Meredith E. Crosby, (unknown), (unknown), Erin E Vaughan, (unknown), (unknown), Diana Clausznitzer, Sylvestre Bonnet, (unknown), Chantal Pont, James Stevens, Sylvia E. Le Dévédec, Bob van de Water	1
4	Lipidomic profiling of triple-negative breast cancer cells reveals distinct metabolic signatures associated with EpCAM expression 2024 ·Talanta ·(unknown), Xinyu Di, (unknown), (unknown), (unknown), (unknown), Alida Kindt, Amy C. Harms, Thomas Hankemeier, Sylvia E. Le Dévédec, Ahmed Ali	1
5	Lactate secreted by glycolytic conjunctival melanoma cells attracts and polarizes macrophages to drive angiogenesis in zebrafish xenografts 2024 ·Angiogenesis ·Jie Yin, Gabriel Forn‐Cuní, (unknown), Bruno Lopes-Bastos, (unknown), Martine J. Jager, Sylvia E. Le Dévédec, (unknown), B. Ewa Snaar‐Jagalska	8
6	Cell viability imaging in tumor spheroids via DNA binding of a ruthenium(ii) light-switch complex 2024 ·Chemical Communications ·Vadde Ramu, (unknown), Nataliia Beztsinna, (unknown), Bob van de Water, Sylvestre Bonnet, Sylvia E. Le Dévédec	5
7	FAIR High Content Screening in Bioimaging 2023 ·Scientific Data ·Rohola Hosseini, (unknown), Joost Willemse, Bob van de Water, Sylvia E. Le Dévédec, Katherine Wolstencroft	3
8	Differential response of luminal and basal breast cancer cells to acute and chronic hypoxia 2023 ·Breast Cancer Research and Treatment ·Qiuyu Liu, (unknown), (unknown), (unknown), Bob van de Water, Erik H.J. Danen, Sylvia E. Le Dévédec	1
9	Development of an Affinity-Based Probe to Profile Endogenous Human Adenosine A ₃ Receptor Expression 2023 ·Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), Rongfang Liu, Anton T. J. Tool, Sylvia E. Le Dévédec, Willem Jespers, Taco W. Kuijpers, Gerard J. P. van Westen, Laura H. Heitman, Adriaan P. IJzerman, Daan van der Es	4
10	Acute vs. chronic vs. intermittent hypoxia in breast Cancer: a review on its application in in vitro research 2022 ·Molecular Biology Reports ·Qiuyu Liu, (unknown), Erik H.J. Danen, Sylvia E. Le Dévédec	23
11	Hypoxia Triggers TAZ Phosphorylation in Basal A Triple Negative Breast Cancer Cells 2022 ·International Journal of Molecular Sciences ·Qiuyu Liu, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Gerard J. P. van Westen, Sylvia E. Le Dévédec, Erik H.J. Danen	5
12	Crosstalk between Hypoxia and Extracellular Matrix in the Tumor Microenvironment in Breast Cancer 2022 ·Genes ·(unknown), Sylvia E. Le Dévédec, Erik H.J. Danen, Qiuyu Liu	38
13	Preclinical models versus clinical renal ischemia reperfusion injury: A systematic review based on metabolic signatures 2021 ·American Journal of Transplantation ·(unknown), (unknown), John F. Mulvey, Sylvia E. Le Dévédec, (unknown), Rob C. I. Wüst, Ian P.J. Alwayn, Rutger J. Ploeg, Alexander F. Schaapherder, Jaap Bakker, J. Lindeman	20
14	Mapping the cellular response to electron transport chain inhibitors reveals selective signaling networks triggered by mitochondrial perturbation 2021 ·Archives of Toxicology ·(unknown), Huan Yang, (unknown), (unknown), (unknown), Giada Carta, (unknown), Johannes Delp, Anna Forsby, Andrew White, Sylvia E. Le Dévédec, Marcel Leist, Paul Jennings, Joost B. Beltman, Bob van de Water, Erik H.J. Danen	9
15	Deubiquitinase Activity Profiling Identifies UCHL1 as a Candidate Oncoprotein That Promotes TGFβ-Induced Breast Cancer Metastasis 2019 ·Clinical Cancer Research ·Sijia Liu, Román González‐Prieto, Mengdi Zhang, Paul P. Geurink, Raymond Kooij, Prasanna Vasudevan Iyengar, Maarten van Dinther, Erik Bos, Xiaobing Zhang, Sylvia E. Le Dévédec, Bob van de Water, Roman I. Koning, Hong‐Jian Zhu, Wilma E. Mesker, Alfred C.O. Vertegaal, Huib Ovaa, Long Zhang, John W.M. Martens, Peter ten Dijke	106
16	The direct oral anticoagulants rivaroxaban and dabigatran do not inhibit orthotopic growth and metastasis of human breast cancer in mice 2019 ·Journal of Thrombosis and Haemostasis ·Jeroen T. Buijs, El Houari Laghmani, Rob F. P. van den Akker, (unknown), (unknown), (unknown), (unknown), (unknown), Sylvia E. Le Dévédec, Gabri van der Pluijm, Henri H. Versteeg	21
17	Uncovering the signaling landscape controlling breast cancer cell migration identifies novel metastasis driver genes 2019 ·Nature Communications ·Esmee Koedoot, (unknown), (unknown), Marcel Smid, (unknown), Hans de Bont, Chantal Pont, (unknown), Steven Wink, Mieke Timmermans, Erik A.C. Wiemer, Peter Stoilov, John A. Foekens, Sylvia E. Le Dévédec, John W.M. Martens, Bob van de Water	60
18	Co-regulated gene expression of splicing factors as drivers of cancer progression 2019 ·Scientific Reports ·Esmee Koedoot, Marcel Smid, John A. Foekens, John W.M. Martens, Sylvia E. Le Dévédec, Bob van de Water	22
19	Phenotype-based cell-specific metabolic modeling reveals metabolic liabilities of cancer 2014 ·eLife ·Keren Yizhak, Edoardo Gaude, Sylvia E. Le Dévédec, Yedael Y. Waldman, Gideon Y. Stein, Bob van de Water, Christian Frezza, Eytan Ruppin	103
20	Two-Photon Intravital Multicolour Imaging to Study Metastatic Behaviour of Cancer Cells In Vivo 2011 ·Methods in molecular biology ·Sylvia E. Le Dévédec, Wies van Roosmalen, Chantal Pont, Reshma A. Lalai, Hans de Bont, Bob van de Water	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact